Prof Pedro Ramirez speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about updates on criteria for patient selection and surgical management in advanced ovarian cancer.

Prof Ramirez gives his insights on assessment methods currently used to identify patients suitable for surgery, new findings on surgery vs neoadjuvant chemotherapy outcomes, recent research on patient selection for surgery and predicting surgical complications in patients undergoing cytoreductive surgery for advanced ovarian cancer.

He concludes by giving his take-home message, which is that each patient needs to be evaluated individually in order to determine which patients are ideal candidates for either neoadjuvant chemotherapy or surgery.